Global Medical Device Validation Service Market

Medical Device Validation Service Comprehensive Study by Technology (Mechanical Testing, Biological, EMI/EMC, Electrical Safety Testing), Service (Microbiology and sterility testing {Antimicrobial testing, Pyrogen and endotoxin testing, Sterility test and validation, Bioburden determination, Other microbiology and sterility testing}, Biocompatibility tests, Chemistry test, Package validation), Therapeutic Area (Cardiovascular, Dermatology, Orthopedics, Nephrology, Respiratory, Neurology, Oncology, ENT, Others) Players and Region - Global Market Outlook to 2032

Medical Device Validation Service Market by XX Submarkets | Forecast Years 2025-2032  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Medical Device Validation Service
The medical devices fulfill the strict specifications imposed by regulatory organizations like the FDA, EMA, and ISO standards, medical device validation services are essential. These services assist manufacturers in verifying the safety, efficacy, and dependability of their products for use in patient care and clinical settings. Verifying the device's functioning, performance, and design under desired circumstances is usually part of the validation process. This guarantees that the product satisfies consumer and regulatory requirements. There are several steps in the validation process. The first is design validation, in which the device's basic idea is examined to make sure it will function as planned. Process validation comes next, which verifies that production procedures continuously yield the required level of product quality.

AttributesDetails
Study Period2020-2032
Base Year2024
UnitValue (USD Million)


Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Charles River (Wilmington, Massachusetts, USA), Element (London, United Kingdom), Eurofins (Luxembourg City, Luxembourg), Intertek (London, United Kingdom), Labcorp (Burlington, North Carolina, USA), NAMSA (Northwood, Ohio, USA), Pace (Cranbury, New Jersey, USA), SGS (Geneva, Switzerland), Sterigenics (Lake Forest, Illinois, USA), TUV SUD (Munich, Germany) and WuXi AppTec (Shanghai, China) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Medical Device Validation Service market by and Region.



On the basis of geography, the market of Medical Device Validation Service has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Mechanical Testing will boost the Medical Device Validation Service market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Service, the sub-segment i.e. Microbiology and sterility testing {Antimicrobial testing, Pyrogen and endotoxin testing, Sterility test and validation, Bioburden determination, Other microbiology and sterility testing} will boost the Medical Device Validation Service market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Therapeutic Area, the sub-segment i.e. Cardiovascular will boost the Medical Device Validation Service market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.



About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Technology
  • Mechanical Testing
  • Biological
  • EMI/EMC
  • Electrical Safety Testing

By Service
  • Microbiology and sterility testing {Antimicrobial testing, Pyrogen and endotoxin testing, Sterility test and validation, Bioburden determination, Other microbiology and sterility testing}
  • Biocompatibility tests
  • Chemistry test
  • Package validation

By Therapeutic Area
  • Cardiovascular
  • Dermatology
  • Orthopedics
  • Nephrology
  • Respiratory
  • Neurology
  • Oncology
  • ENT
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Factor Analysis
    • 3.1. Porters Five Forces
    • 3.2. Supply/Value Chain
    • 3.3. PESTEL analysis
    • 3.4. Market Entropy
    • 3.5. Patent/Trademark Analysis
  • 4. Global Medical Device Validation Service, by Technology, Service, Therapeutic Area and Region (value) (2019-2024)
    • 4.1. Introduction
    • 4.2. Global Medical Device Validation Service (Value)
      • 4.2.1. Global Medical Device Validation Service by: Technology (Value)
        • 4.2.1.1. Mechanical Testing
        • 4.2.1.2. Biological
        • 4.2.1.3. EMI/EMC
        • 4.2.1.4. Electrical Safety Testing
      • 4.2.2. Global Medical Device Validation Service by: Service (Value)
        • 4.2.2.1. Microbiology and sterility testing {Antimicrobial testing, Pyrogen and endotoxin testing, Sterility test and validation, Bioburden determination, Other microbiology and sterility testing}
        • 4.2.2.2. Biocompatibility tests
        • 4.2.2.3. Chemistry test
        • 4.2.2.4. Package validation
      • 4.2.3. Global Medical Device Validation Service by: Therapeutic Area (Value)
        • 4.2.3.1. Cardiovascular
        • 4.2.3.2. Dermatology
        • 4.2.3.3. Orthopedics
        • 4.2.3.4. Nephrology
        • 4.2.3.5. Respiratory
        • 4.2.3.6. Neurology
        • 4.2.3.7. Oncology
        • 4.2.3.8. ENT
        • 4.2.3.9. Others
      • 4.2.4. Global Medical Device Validation Service Region
        • 4.2.4.1. South America
          • 4.2.4.1.1. Brazil
          • 4.2.4.1.2. Argentina
          • 4.2.4.1.3. Rest of South America
        • 4.2.4.2. Asia Pacific
          • 4.2.4.2.1. China
          • 4.2.4.2.2. Japan
          • 4.2.4.2.3. India
          • 4.2.4.2.4. South Korea
          • 4.2.4.2.5. Taiwan
          • 4.2.4.2.6. Australia
          • 4.2.4.2.7. Rest of Asia-Pacific
        • 4.2.4.3. Europe
          • 4.2.4.3.1. Germany
          • 4.2.4.3.2. France
          • 4.2.4.3.3. Italy
          • 4.2.4.3.4. United Kingdom
          • 4.2.4.3.5. Netherlands
          • 4.2.4.3.6. Rest of Europe
        • 4.2.4.4. MEA
          • 4.2.4.4.1. Middle East
          • 4.2.4.4.2. Africa
        • 4.2.4.5. North America
          • 4.2.4.5.1. United States
          • 4.2.4.5.2. Canada
          • 4.2.4.5.3. Mexico
  • 5. Medical Device Validation Service: Manufacturers/Players Analysis
    • 5.1. Competitive Landscape
      • 5.1.1. Market Share Analysis
        • 5.1.1.1. Top 3
        • 5.1.1.2. Top 5
    • 5.2. Peer Group Analysis (2024)
    • 5.3. BCG Matrix
    • 5.4. Company Profile
      • 5.4.1. Charles River (Wilmington, Massachusetts, USA)
        • 5.4.1.1. Business Overview
        • 5.4.1.2. Products/Services Offerings
        • 5.4.1.3. Financial Analysis
        • 5.4.1.4. SWOT Analysis
      • 5.4.2. Element (London, United Kingdom)
        • 5.4.2.1. Business Overview
        • 5.4.2.2. Products/Services Offerings
        • 5.4.2.3. Financial Analysis
        • 5.4.2.4. SWOT Analysis
      • 5.4.3. Eurofins (Luxembourg City, Luxembourg)
        • 5.4.3.1. Business Overview
        • 5.4.3.2. Products/Services Offerings
        • 5.4.3.3. Financial Analysis
        • 5.4.3.4. SWOT Analysis
      • 5.4.4. Intertek (London, United Kingdom)
        • 5.4.4.1. Business Overview
        • 5.4.4.2. Products/Services Offerings
        • 5.4.4.3. Financial Analysis
        • 5.4.4.4. SWOT Analysis
      • 5.4.5. Labcorp (Burlington, North Carolina, USA)
        • 5.4.5.1. Business Overview
        • 5.4.5.2. Products/Services Offerings
        • 5.4.5.3. Financial Analysis
        • 5.4.5.4. SWOT Analysis
      • 5.4.6. NAMSA (Northwood, Ohio, USA)
        • 5.4.6.1. Business Overview
        • 5.4.6.2. Products/Services Offerings
        • 5.4.6.3. Financial Analysis
        • 5.4.6.4. SWOT Analysis
      • 5.4.7. Pace (Cranbury, New Jersey, USA)
        • 5.4.7.1. Business Overview
        • 5.4.7.2. Products/Services Offerings
        • 5.4.7.3. Financial Analysis
        • 5.4.7.4. SWOT Analysis
      • 5.4.8. SGS (Geneva, Switzerland)
        • 5.4.8.1. Business Overview
        • 5.4.8.2. Products/Services Offerings
        • 5.4.8.3. Financial Analysis
        • 5.4.8.4. SWOT Analysis
      • 5.4.9. Sterigenics (Lake Forest, Illinois, USA)
        • 5.4.9.1. Business Overview
        • 5.4.9.2. Products/Services Offerings
        • 5.4.9.3. Financial Analysis
        • 5.4.9.4. SWOT Analysis
      • 5.4.10. TUV SUD (Munich, Germany)
        • 5.4.10.1. Business Overview
        • 5.4.10.2. Products/Services Offerings
        • 5.4.10.3. Financial Analysis
        • 5.4.10.4. SWOT Analysis
      • 5.4.11. WuXi AppTec (Shanghai, China)
        • 5.4.11.1. Business Overview
        • 5.4.11.2. Products/Services Offerings
        • 5.4.11.3. Financial Analysis
        • 5.4.11.4. SWOT Analysis
  • 6. Global Medical Device Validation Service Sale, by Technology, Service, Therapeutic Area and Region (value) (2027-2032)
    • 6.1. Introduction
    • 6.2. Global Medical Device Validation Service (Value)
      • 6.2.1. Global Medical Device Validation Service by: Technology (Value)
        • 6.2.1.1. Mechanical Testing
        • 6.2.1.2. Biological
        • 6.2.1.3. EMI/EMC
        • 6.2.1.4. Electrical Safety Testing
      • 6.2.2. Global Medical Device Validation Service by: Service (Value)
        • 6.2.2.1. Microbiology and sterility testing {Antimicrobial testing, Pyrogen and endotoxin testing, Sterility test and validation, Bioburden determination, Other microbiology and sterility testing}
        • 6.2.2.2. Biocompatibility tests
        • 6.2.2.3. Chemistry test
        • 6.2.2.4. Package validation
      • 6.2.3. Global Medical Device Validation Service by: Therapeutic Area (Value)
        • 6.2.3.1. Cardiovascular
        • 6.2.3.2. Dermatology
        • 6.2.3.3. Orthopedics
        • 6.2.3.4. Nephrology
        • 6.2.3.5. Respiratory
        • 6.2.3.6. Neurology
        • 6.2.3.7. Oncology
        • 6.2.3.8. ENT
        • 6.2.3.9. Others
      • 6.2.4. Global Medical Device Validation Service Region
        • 6.2.4.1. South America
          • 6.2.4.1.1. Brazil
          • 6.2.4.1.2. Argentina
          • 6.2.4.1.3. Rest of South America
        • 6.2.4.2. Asia Pacific
          • 6.2.4.2.1. China
          • 6.2.4.2.2. Japan
          • 6.2.4.2.3. India
          • 6.2.4.2.4. South Korea
          • 6.2.4.2.5. Taiwan
          • 6.2.4.2.6. Australia
          • 6.2.4.2.7. Rest of Asia-Pacific
        • 6.2.4.3. Europe
          • 6.2.4.3.1. Germany
          • 6.2.4.3.2. France
          • 6.2.4.3.3. Italy
          • 6.2.4.3.4. United Kingdom
          • 6.2.4.3.5. Netherlands
          • 6.2.4.3.6. Rest of Europe
        • 6.2.4.4. MEA
          • 6.2.4.4.1. Middle East
          • 6.2.4.4.2. Africa
        • 6.2.4.5. North America
          • 6.2.4.5.1. United States
          • 6.2.4.5.2. Canada
          • 6.2.4.5.3. Mexico
  • 7. Appendix
    • 7.1. Acronyms
  • 8. Methodology and Data Source
    • 8.1. Methodology/Research Approach
      • 8.1.1. Research Programs/Design
      • 8.1.2. Market Size Estimation
      • 8.1.3. Market Breakdown and Data Triangulation
    • 8.2. Data Source
      • 8.2.1. Secondary Sources
      • 8.2.2. Primary Sources
    • 8.3. Disclaimer
List of Tables
  • Table 1. Medical Device Validation Service: by Technology(USD Million)
  • Table 2. Medical Device Validation Service Mechanical Testing , by Region USD Million (2019-2024)
  • Table 3. Medical Device Validation Service Biological , by Region USD Million (2019-2024)
  • Table 4. Medical Device Validation Service EMI/EMC , by Region USD Million (2019-2024)
  • Table 5. Medical Device Validation Service Electrical Safety Testing , by Region USD Million (2019-2024)
  • Table 6. Medical Device Validation Service: by Service(USD Million)
  • Table 7. Medical Device Validation Service Microbiology and sterility testing {Antimicrobial testing, Pyrogen and endotoxin testing, Sterility test and validation, Bioburden determination, Other microbiology and sterility testing} , by Region USD Million (2019-2024)
  • Table 8. Medical Device Validation Service Biocompatibility tests , by Region USD Million (2019-2024)
  • Table 9. Medical Device Validation Service Chemistry test , by Region USD Million (2019-2024)
  • Table 10. Medical Device Validation Service Package validation , by Region USD Million (2019-2024)
  • Table 11. Medical Device Validation Service: by Therapeutic Area(USD Million)
  • Table 12. Medical Device Validation Service Cardiovascular , by Region USD Million (2019-2024)
  • Table 13. Medical Device Validation Service Dermatology , by Region USD Million (2019-2024)
  • Table 14. Medical Device Validation Service Orthopedics , by Region USD Million (2019-2024)
  • Table 15. Medical Device Validation Service Nephrology , by Region USD Million (2019-2024)
  • Table 16. Medical Device Validation Service Respiratory , by Region USD Million (2019-2024)
  • Table 17. Medical Device Validation Service Neurology , by Region USD Million (2019-2024)
  • Table 18. Medical Device Validation Service Oncology , by Region USD Million (2019-2024)
  • Table 19. Medical Device Validation Service ENT , by Region USD Million (2019-2024)
  • Table 20. Medical Device Validation Service Others , by Region USD Million (2019-2024)
  • Table 21. South America Medical Device Validation Service, by Country USD Million (2019-2024)
  • Table 22. South America Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 23. South America Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 24. South America Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 25. Brazil Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 26. Brazil Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 27. Brazil Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 28. Argentina Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 29. Argentina Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 30. Argentina Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 31. Rest of South America Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 32. Rest of South America Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 33. Rest of South America Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 34. Asia Pacific Medical Device Validation Service, by Country USD Million (2019-2024)
  • Table 35. Asia Pacific Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 36. Asia Pacific Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 37. Asia Pacific Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 38. China Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 39. China Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 40. China Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 41. Japan Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 42. Japan Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 43. Japan Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 44. India Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 45. India Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 46. India Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 47. South Korea Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 48. South Korea Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 49. South Korea Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 50. Taiwan Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 51. Taiwan Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 52. Taiwan Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 53. Australia Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 54. Australia Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 55. Australia Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 56. Rest of Asia-Pacific Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 57. Rest of Asia-Pacific Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 58. Rest of Asia-Pacific Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 59. Europe Medical Device Validation Service, by Country USD Million (2019-2024)
  • Table 60. Europe Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 61. Europe Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 62. Europe Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 63. Germany Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 64. Germany Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 65. Germany Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 66. France Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 67. France Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 68. France Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 69. Italy Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 70. Italy Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 71. Italy Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 72. United Kingdom Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 73. United Kingdom Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 74. United Kingdom Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 75. Netherlands Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 76. Netherlands Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 77. Netherlands Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 78. Rest of Europe Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 79. Rest of Europe Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 80. Rest of Europe Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 81. MEA Medical Device Validation Service, by Country USD Million (2019-2024)
  • Table 82. MEA Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 83. MEA Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 84. MEA Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 85. Middle East Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 86. Middle East Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 87. Middle East Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 88. Africa Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 89. Africa Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 90. Africa Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 91. North America Medical Device Validation Service, by Country USD Million (2019-2024)
  • Table 92. North America Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 93. North America Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 94. North America Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 95. United States Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 96. United States Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 97. United States Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 98. Canada Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 99. Canada Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 100. Canada Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 101. Mexico Medical Device Validation Service, by Technology USD Million (2019-2024)
  • Table 102. Mexico Medical Device Validation Service, by Service USD Million (2019-2024)
  • Table 103. Mexico Medical Device Validation Service, by Therapeutic Area USD Million (2019-2024)
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Medical Device Validation Service: by Technology(USD Million)
  • Table 116. Medical Device Validation Service Mechanical Testing , by Region USD Million (2027-2032)
  • Table 117. Medical Device Validation Service Biological , by Region USD Million (2027-2032)
  • Table 118. Medical Device Validation Service EMI/EMC , by Region USD Million (2027-2032)
  • Table 119. Medical Device Validation Service Electrical Safety Testing , by Region USD Million (2027-2032)
  • Table 120. Medical Device Validation Service: by Service(USD Million)
  • Table 121. Medical Device Validation Service Microbiology and sterility testing {Antimicrobial testing, Pyrogen and endotoxin testing, Sterility test and validation, Bioburden determination, Other microbiology and sterility testing} , by Region USD Million (2027-2032)
  • Table 122. Medical Device Validation Service Biocompatibility tests , by Region USD Million (2027-2032)
  • Table 123. Medical Device Validation Service Chemistry test , by Region USD Million (2027-2032)
  • Table 124. Medical Device Validation Service Package validation , by Region USD Million (2027-2032)
  • Table 125. Medical Device Validation Service: by Therapeutic Area(USD Million)
  • Table 126. Medical Device Validation Service Cardiovascular , by Region USD Million (2027-2032)
  • Table 127. Medical Device Validation Service Dermatology , by Region USD Million (2027-2032)
  • Table 128. Medical Device Validation Service Orthopedics , by Region USD Million (2027-2032)
  • Table 129. Medical Device Validation Service Nephrology , by Region USD Million (2027-2032)
  • Table 130. Medical Device Validation Service Respiratory , by Region USD Million (2027-2032)
  • Table 131. Medical Device Validation Service Neurology , by Region USD Million (2027-2032)
  • Table 132. Medical Device Validation Service Oncology , by Region USD Million (2027-2032)
  • Table 133. Medical Device Validation Service ENT , by Region USD Million (2027-2032)
  • Table 134. Medical Device Validation Service Others , by Region USD Million (2027-2032)
  • Table 135. South America Medical Device Validation Service, by Country USD Million (2027-2032)
  • Table 136. South America Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 137. South America Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 138. South America Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 139. Brazil Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 140. Brazil Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 141. Brazil Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 142. Argentina Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 143. Argentina Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 144. Argentina Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 145. Rest of South America Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 146. Rest of South America Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 147. Rest of South America Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 148. Asia Pacific Medical Device Validation Service, by Country USD Million (2027-2032)
  • Table 149. Asia Pacific Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 150. Asia Pacific Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 151. Asia Pacific Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 152. China Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 153. China Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 154. China Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 155. Japan Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 156. Japan Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 157. Japan Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 158. India Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 159. India Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 160. India Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 161. South Korea Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 162. South Korea Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 163. South Korea Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 164. Taiwan Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 165. Taiwan Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 166. Taiwan Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 167. Australia Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 168. Australia Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 169. Australia Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 170. Rest of Asia-Pacific Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 171. Rest of Asia-Pacific Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 172. Rest of Asia-Pacific Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 173. Europe Medical Device Validation Service, by Country USD Million (2027-2032)
  • Table 174. Europe Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 175. Europe Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 176. Europe Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 177. Germany Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 178. Germany Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 179. Germany Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 180. France Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 181. France Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 182. France Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 183. Italy Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 184. Italy Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 185. Italy Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 186. United Kingdom Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 187. United Kingdom Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 188. United Kingdom Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 189. Netherlands Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 190. Netherlands Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 191. Netherlands Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 192. Rest of Europe Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 193. Rest of Europe Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 194. Rest of Europe Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 195. MEA Medical Device Validation Service, by Country USD Million (2027-2032)
  • Table 196. MEA Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 197. MEA Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 198. MEA Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 199. Middle East Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 200. Middle East Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 201. Middle East Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 202. Africa Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 203. Africa Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 204. Africa Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 205. North America Medical Device Validation Service, by Country USD Million (2027-2032)
  • Table 206. North America Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 207. North America Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 208. North America Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 209. United States Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 210. United States Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 211. United States Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 212. Canada Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 213. Canada Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 214. Canada Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 215. Mexico Medical Device Validation Service, by Technology USD Million (2027-2032)
  • Table 216. Mexico Medical Device Validation Service, by Service USD Million (2027-2032)
  • Table 217. Mexico Medical Device Validation Service, by Therapeutic Area USD Million (2027-2032)
  • Table 218. Research Programs/Design for This Report
  • Table 219. Key Data Information from Secondary Sources
  • Table 220. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Medical Device Validation Service: by Technology USD Million (2019-2024)
  • Figure 5. Global Medical Device Validation Service: by Service USD Million (2019-2024)
  • Figure 6. Global Medical Device Validation Service: by Therapeutic Area USD Million (2019-2024)
  • Figure 7. South America Medical Device Validation Service Share (%), by Country
  • Figure 8. Asia Pacific Medical Device Validation Service Share (%), by Country
  • Figure 9. Europe Medical Device Validation Service Share (%), by Country
  • Figure 10. MEA Medical Device Validation Service Share (%), by Country
  • Figure 11. North America Medical Device Validation Service Share (%), by Country
  • Figure 12. Global Medical Device Validation Service share by Players 2024 (%)
  • Figure 13. Global Medical Device Validation Service share by Players (Top 3) 2024(%)
  • Figure 14. Global Medical Device Validation Service share by Players (Top 5) 2024(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Charles River (Wilmington, Massachusetts, USA) Revenue, Net Income and Gross profit
  • Figure 17. Charles River (Wilmington, Massachusetts, USA) Revenue: by Geography 2024
  • Figure 18. Element (London, United Kingdom) Revenue, Net Income and Gross profit
  • Figure 19. Element (London, United Kingdom) Revenue: by Geography 2024
  • Figure 20. Eurofins (Luxembourg City, Luxembourg) Revenue, Net Income and Gross profit
  • Figure 21. Eurofins (Luxembourg City, Luxembourg) Revenue: by Geography 2024
  • Figure 22. Intertek (London, United Kingdom) Revenue, Net Income and Gross profit
  • Figure 23. Intertek (London, United Kingdom) Revenue: by Geography 2024
  • Figure 24. Labcorp (Burlington, North Carolina, USA) Revenue, Net Income and Gross profit
  • Figure 25. Labcorp (Burlington, North Carolina, USA) Revenue: by Geography 2024
  • Figure 26. NAMSA (Northwood, Ohio, USA) Revenue, Net Income and Gross profit
  • Figure 27. NAMSA (Northwood, Ohio, USA) Revenue: by Geography 2024
  • Figure 28. Pace (Cranbury, New Jersey, USA) Revenue, Net Income and Gross profit
  • Figure 29. Pace (Cranbury, New Jersey, USA) Revenue: by Geography 2024
  • Figure 30. SGS (Geneva, Switzerland) Revenue, Net Income and Gross profit
  • Figure 31. SGS (Geneva, Switzerland) Revenue: by Geography 2024
  • Figure 32. Sterigenics (Lake Forest, Illinois, USA) Revenue, Net Income and Gross profit
  • Figure 33. Sterigenics (Lake Forest, Illinois, USA) Revenue: by Geography 2024
  • Figure 34. TUV SUD (Munich, Germany) Revenue, Net Income and Gross profit
  • Figure 35. TUV SUD (Munich, Germany) Revenue: by Geography 2024
  • Figure 36. WuXi AppTec (Shanghai, China) Revenue, Net Income and Gross profit
  • Figure 37. WuXi AppTec (Shanghai, China) Revenue: by Geography 2024
  • Figure 38. Global Medical Device Validation Service: by Technology USD Million (2027-2032)
  • Figure 39. Global Medical Device Validation Service: by Service USD Million (2027-2032)
  • Figure 40. Global Medical Device Validation Service: by Therapeutic Area USD Million (2027-2032)
  • Figure 41. South America Medical Device Validation Service Share (%), by Country
  • Figure 42. Asia Pacific Medical Device Validation Service Share (%), by Country
  • Figure 43. Europe Medical Device Validation Service Share (%), by Country
  • Figure 44. MEA Medical Device Validation Service Share (%), by Country
  • Figure 45. North America Medical Device Validation Service Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Charles River (Wilmington, Massachusetts, USA)
  • Element (London, United Kingdom)
  • Eurofins (Luxembourg City, Luxembourg)
  • Intertek (London, United Kingdom)
  • Labcorp (Burlington, North Carolina, USA)
  • NAMSA (Northwood, Ohio, USA)
  • Pace (Cranbury, New Jersey, USA)
  • SGS (Geneva, Switzerland)
  • Sterigenics (Lake Forest, Illinois, USA)
  • TUV SUD (Munich, Germany)
  • WuXi AppTec (Shanghai, China)
Select User Access Type

Key Highlights of Report


Mar 2025 217 Pages 65 Tables Base Year: 2024 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Medical Device Validation Service Market Quantitative research analysis
Global Medical Device Validation Service Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Charles River (Wilmington, Massachusetts, USA), Element (London, United Kingdom), Eurofins (Luxembourg City, Luxembourg), Intertek (London, United Kingdom), Labcorp (Burlington, North Carolina, USA), NAMSA (Northwood, Ohio, USA), Pace (Cranbury, New Jersey, USA), SGS (Geneva, Switzerland), Sterigenics (Lake Forest, Illinois, USA), TUV SUD (Munich, Germany) and WuXi AppTec (Shanghai, China) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"" is seen as one of major influencing trends for Medical Device Validation Service Market during projected period 2024-2032.
The Medical Device Validation Service market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Medical Device Validation Service Market Report?

Have a Query? Click Here

Other Related Reports

Medical Device Analytical Testing Outsourcing- Comprehensive Study by Testing Type (Biological Testing, Chemical Testing, Physical Testing, Sterilization Testing), Device Type (In-Vitro Diagnostic De...
$ 3800
Prosthetics & Orthotics Comprehensive Study by Type (Prosthetics (Artificial Legs, Artificial Hands, Upper Limb Prosthetics, Lower Limb Prosthetics), Orthotics (Knee Braces and Supports, Ankle Braces...
$ 3800
Infrared Thermometer- Comprehensive Study by Type (Fixed Infrared Thermometer, Portable Infrared Thermometer), Application (Non-medical, Medical), Distribution Channel (Hypermarket/Supermarket, Onlin...
$ 3800
Needle free connector Comprehensive Study by Type (Simple Connector, Complex Connector), Application (Intravenous Therapy, Eternal Feeding, Blood Collection, Others), Material (Polycarbonate, Polypro...
$ 3800
Silicone Phacosleeve Comprehensive Study by Phaco Tips (Classic /Hypersonic, Microsonic /Lesieur, Subsonic, Nano), Distribution Channel (Online, Offline), Size (2.8 mm, 2.5 mm, 2.2 mm, 1.8 mm, Others...
$ 3800
Wearable Breast Pumps Comprehensive Study by Type (Single Wearable Breast Pumps, Double Wearable Breast Pumps), Application (Personal Use, Hospital & Clinics), Distribution Channel (Specialty Stores...
$ 3800